Publications by authors named "Viswanath Devanarayan"

Claim this Profile
C
Combining CSF MTBR-tau243 and plasma pTau217 ratio enhances the prediction of continuous regional tau PET burden in early Alzheimer's disease.
Viswanath Devanarayan, Kanta Horie, Kristin Wildsmith, Thomas Doherty, Erica Andreozzi

Alzheimers Dement· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk prediction of mild cognitive impairment using electronic health record data.
Gang Li, Bryan Cobb, Todd M Nelson, Viswanath Devanarayan, Stephane Borentain

Alzheimers Dement (Amst)· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multimodal prognostic modeling of individual cognitive trajectories to enhance trial efficiency in preclinical Alzheimer's disease.
Viswanath Devanarayan, Michael C Donohue, Reisa A Sperling, Keith A Johnson, Yuanqing Ye

Alzheimers Dement· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The impact of real-world evidence in implementing and optimizing Alzheimer's disease care.
Harald Hampel, Gang Li, Michelle M Mielke, James E Galvin, Miia Kivipelto, Viswanath Devanarayan

Med· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predicted natural progression as an Alzheimer's prognostic covariate improves the precision of lecanemab efficacy assessments and clinical trial efficiency.
Viswanath Devanarayan, Yuanqing Ye, Liang Zhu, Lu Tian, Lynn Kramer

Alzheimers Dement· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Plasma pTau217 ratio predicts continuous regional brain tau accumulation in amyloid-positive early Alzheimer's disease.
Viswanath Devanarayan, Arnaud Charil, Kanta Horie, Thomas Doherty, Daniel A Llano

Alzheimers Dement· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Plasma pTau217 predicts continuous brain amyloid levels in preclinical and early Alzheimer's disease.
Viswanath Devanarayan, Thomas Doherty, Arnaud Charil, Pallavi Sachdev, Yuanqing Ye

Alzheimers Dement· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Plasma pTau181 enhances the prediction of future clinical decline in amyloid-positive mild cognitive impairment.
Viswanath Devanarayan, Daniel A Llano, Yan Helen Hu, Harald Hampel, Lynn Kramer

Alzheimers Dement (Amst)· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predicting clinical progression trajectories of early Alzheimer's disease patients.
Viswanath Devanarayan, Yuanqing Ye, Arnaud Charil, Erica Andreozzi, Pallavi Sachdev

Alzheimers Dement· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Proceedings of the 14th European immunogenicity platform open symposium on immunogenicity of biopharmaceuticals.
Sophie Tourdot, Daniel Baltrunkonis, Sofie Denies, Viswanath Devanarayan, Joanna Grudzinska-Goebel

MAbs· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The age-specific comorbidity burden of mild cognitive impairment: a US claims database study.
Gang Li, Nicola Toschi, Viswanath Devanarayan, Richard Batrla, Tommaso Boccato

Alzheimers Res Ther· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improving the Robustness of Variable Selection and Predictive Performance of Regularized Generalized Linear Models and Cox Proportional Hazard Models.
Feng Hong, Lu Tian, Viswanath Devanarayan

Mathematics (Basel)· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CSF peptides from VGF and other markers enhance prediction of MCI to AD progression using the ATN framework.
Daniel A Llano, Priya Devanarayan, Viswanath Devanarayan,

Neurobiol Aging· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predictive signature development based on maximizing the area between receiver operating characteristic curves.
Xin Huang, Lu Tian, Yan Sun, Saptarshi Chatterjee, Viswanath Devanarayan

Stat Med· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of Titer and Signal to Noise (S/N) for Determination of Anti-drug Antibody Magnitude Using Clinical Data from an Industry Consortium.
Marta Starcevic Manning, Mohamed Hassanein, Michael A Partridge, Vibha Jawa, Johanna Mora, Viswanath Devanarayan

AAPS J· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reporting guidelines for human microbiome research: the STORMS checklist.
Chloe Mirzayi, Audrey Renson, , , Fatima Zohra, Viswanath Devanarayan

Nat Med· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Serum Phosphatidylethanolamine and Lysophosphatidylethanolamine Levels Differentiate Alzheimer's Disease from Controls and Predict Progression from Mild Cognitive Impairment.
Daniel A Llano, Viswanath Devanarayan,

J Alzheimers Dis· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reported Hearing Loss in Alzheimer's Disease Is Associated With Loss of Brainstem and Cerebellar Volume.
Daniel A Llano, Susanna S Kwok, Viswanath Devanarayan,

Front Hum Neurosci· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hearing Loss in Alzheimer's Disease Is Associated with Altered Serum Lipidomic Biomarker Profiles.
Daniel A Llano, Lina K Issa, Priya Devanarayan, Viswanath Devanarayan, Alzheimer's Disease Neuroimaging Initiative Adni

Cells· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Are Lessons Learned in Setting Cut Points for Detection of Anti-Drug Antibodies Also Useful in Serology Assays for Robust Detection of SARS-CoV-2 Reactive Antibodies?
Ronald R Bowsher, Viswanath Devanarayan

AAPS J· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
VGF in Cerebrospinal Fluid Combined With Conventional Biomarkers Enhances Prediction of Conversion From MCI to AD.
Daniel A Llano, Priya Devanarayan, Viswanath Devanarayan,

Alzheimer Dis Assoc Disord· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recommendations for the Development and Validation of Immunogenicity Assays in Support of Biosimilar Programs.
Francesca Civoli, Aparna Kasinath, Xiao-Yan Cai, Meenu Wadhwa, Andrew Exley, Viswanath Devanarayan

AAPS J· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Report on the AAPS Immunogenicity Guidance Forum.
Heather Myler, Boris Gorovits, Kelli Phillips, Viswanath Devanarayan, Adrienne Clements-Egan

AAPS J· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis